6qdr Citations

Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth.

Cell Chem Biol 27 657-667.e6 (2020)
Related entries: 6qds, 6qdt, 6qdu

Cited: 13 times
EuropePMC logo PMID: 32220335

Abstract

Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.

Reviews citing this publication (5)

Articles citing this publication (8)

  1. Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms. Gogl G, Tugaeva KV, Eberling P, Kostmann C, Trave G, Sluchanko NN. Nat Commun 12 1677 (2021)
  2. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products. Wolter M, de Vink P, Neves JF, Srdanović S, Higuchi Y, Kato N, Wilson A, Landrieu I, Brunsveld L, Ottmann C. J Am Chem Soc 142 11772-11783 (2020)
  3. Targeting the Surface of the Protein 14-3-3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf. Ruks T, Loza K, Heggen M, Ottmann C, Bayer P, Beuck C, Epple M. Chembiochem 22 1456-1463 (2021)
  4. Genetic encoding of 3-nitro-tyrosine reveals the impacts of 14-3-3 nitration on client binding and dephosphorylation. Zhu P, Nguyen KT, Estelle AB, Sluchanko NN, Mehl RA, Cooley RB. Protein Sci 32 e4574 (2023)
  5. A new soaking procedure for X-ray crystallographic structural determination of protein-peptide complexes. Ballone A, Lau RA, Zweipfenning FPA, Ottmann C. Acta Crystallogr F Struct Biol Commun 76 501-507 (2020)
  6. 007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents. Gannon M, Yacoubian TA. Trends Pharmacol Sci 41 431-433 (2020)
  7. Characterization of a new fusicoccane-type diterpene synthase and an associated P450 enzyme. Huang JH, Lv JM, Xiao LY, Xu Q, Lin FL, Wang GQ, Chen GD, Qin SY, Hu D, Gao H. Beilstein J Org Chem 18 1396-1402 (2022)
  8. Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein-Protein Interaction from Nonselective Fragments. Konstantinidou M, Visser EJ, Vandenboorn E, Chen S, Jaishankar P, Overmans M, Dutta S, Neitz RJ, Renslo AR, Ottmann C, Brunsveld L, Arkin MR. J Am Chem Soc 145 20328-20343 (2023)